Zibo Zhao

Zibo Zhao

Auto-generated profile, based on publicly available information

Zibo Zhao

Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
ZZZibo Zhao
Zibo Zhao
ASAli Shilatifard
Ali Shilatifard
The epigenetic modifications of histones are versatile marks that are intimately connected to development and disease pathogenesis including human cancers. In this review, we will discuss the many different types of histone modifications and the biological processes with which they are involved. Specifically, we review the enzymatic machineries and modifications that are involved in cancer development and progression, and how to apply currently available small molecule inhibitors for histone modifiers as tool compounds to study the functional significance of histone modifications and their clinical implications.

11 May 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
DDDelphine Douillet
Delphine Douillet
CSChristie C. Sze
Christie C. Sze
CRCaila Ryan
Caila Ryan
APAndrea Piunti
Andrea Piunti
ASAvani P. Shah
Avani P. Shah
ASAli Shilatifard
Ali Shilatifard

29 March 2024 in Science
Verified
Journal Article
Closed access
USUmakant Sahu
Umakant Sahu
EVElodie Villa
Elodie Villa
CRColleen R. Reczek
Colleen R. Reczek
ZZZibo Zhao
Zibo Zhao
BOBrendan P. O’hAra
Brendan P. O’hAra
ISIssam BEN SAHRA
Issam BEN SAHRA
Cellular purines, particularly adenosine 5′-triphosphate (ATP), fuel many metabolic reactions, but less is known about the direct effects of pyrimidines on cellular metabolism. We found that pyrimidines, but not purines, maintain pyruvate oxidation and the tricarboxylic citric acid (TCA) cycle by regulating pyruvate dehydrogenase (PDH) activity. PDH activity requires sufficient substrates and cofactors, including thiamine pyrophosphate (TPP). Depletion of cellular pyrimidines decreased TPP synthesis, a reaction carried out by TPP kinase 1 (TPK1), which reportedly uses ATP to phosphorylate thiamine (vitamin B1). We found that uridine 5′-triphosphate (UTP) acts as the preferred substrate for TPK1, enabling cellular TPP synthesis, PDH activity, TCA-cycle activity, lipogenesis, and adipocyte differentiation. Thus, UTP is required for vitamin B1 utilization to maintain pyruvate oxidation and lipogenesis.

7 October 2022 in Science Advances
Verified
Journal Article
Open access
ASAileen Patricia Szczepanski
Aileen Patricia Szczepanski
NTNatsumi Tsuboyama
Natsumi Tsuboyama
JWJun Watanabe
Jun Watanabe
RHRintaro Hashizume
Rintaro Hashizume
ZZZibo Zhao
Zibo Zhao
LWLu Wang
Lu Wang
Small cell lung cancer (SCLC), accounting for around 13% of all lung cancers, often results in rapid tumor growth, early metastasis, and acquired therapeutic resistance. The POU class 2 homeobox 3 (POU2F3) is a master regulator of tuft cell identity and defines the SCLC-P subtype that lacks the neuroendocrine markers. Here, we have identified a previously uncharacterized protein, C11orf53, which is coexpressed with POU2F3 in both SCLC cell lines and patient samples. Mechanistically, C11orf53 directly interacts with POU2F3 and is recruited to chromatin by POU2F3. Depletion of C11orf53 reduced enhancer H3K27ac levels and chromatin accessibility, resulting in a reduction of POU2F3-dependent gene expression. On the basis of the molecular function of C11orf53, we renamed it as “POU Class 2 Homeobox Associating Factor 2” (POU2AF2). In summary, our study has identified a new coactivator of POU2F3 and sheds light on the therapeutic potential of targeting POU2AF2/POU2F3 heterodimer in human SCLC.

5 July 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
ZZZibo Zhao
Zibo Zhao
LWLu Wang
Lu Wang
EBElizabeth Bartom
Elizabeth Bartom
SMStacy Marshall
Stacy Marshall
EREmily Rendleman
Emily Rendleman
ASAli Shilatifard
Ali Shilatifard
Zic family proteins regulate GLUT1 gene expression in a β-catenin/Tcf7l2–dependent manner in colorectal cancer cells.

7 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ASAileen Szczepanski
Aileen Szczepanski
NTNatsumi Tsuboyama
Natsumi Tsuboyama
HLHuijue Lyu
Huijue Lyu
PWPing Wang
Ping Wang
OBOguzhan Beytullahoglu
Oguzhan Beytullahoglu
LWLu Wang
Lu Wang
Recent studies have identified a previously uncharacterized protein C11orf53 (now named POU2AF2/OCA-T1), which functions as a robust co-activator of POU2F3, the master transcription factor which is critical for both normal and neoplastic tuft cell identity and viability. Here, we demonstrate that POU2AF2 dictates opposing transcriptional regulation at distal enhance elements. Loss of POU2AF2 leads to an inhibition of active enhancer nearby genes, such as tuft cell identity genes, and a derepression of Polycomb-dependent poised enhancer nearby genes, which are critical for cell viability and differentiation. Mechanistically, depletion of POU2AF2 results in a global redistribution of the chromatin occupancy of the SWI/SNF complex, leading to a significant 3D genome structure change and a subsequent transcriptional reprogramming. Our genome-wide CRISPR screen further demonstrates that POU2AF2 depletion or SWI/SNF inhibition leads to a PTEN-dependent cell growth defect, highlighting a potential role of POU2AF2-SWI/SNF axis in small cell lung cancer (SCLC) pathogenesis. Additionally, pharmacological inhibition of SWI/SNF phenocopies POU2AF2 depletion in terms of gene expression alteration and cell viability decrease in SCLC-P subtype cells. Therefore, impeding POU2AF2-mediated transcriptional regulation represents a potential therapeutic approach for human SCLC therapy.